PT946546E - Derivados da piridin-2-il-metilamina processo de preparacao e aplicacao daqueles como medicamentos - Google Patents
Derivados da piridin-2-il-metilamina processo de preparacao e aplicacao daqueles como medicamentosInfo
- Publication number
- PT946546E PT946546E PT97947107T PT97947107T PT946546E PT 946546 E PT946546 E PT 946546E PT 97947107 T PT97947107 T PT 97947107T PT 97947107 T PT97947107 T PT 97947107T PT 946546 E PT946546 E PT 946546E
- Authority
- PT
- Portugal
- Prior art keywords
- represents hydrogen
- methyl
- fluorine
- pct
- chlorine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614217A FR2755967B1 (fr) | 1996-11-21 | 1996-11-21 | Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT946546E true PT946546E (pt) | 2003-11-28 |
Family
ID=9497861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97947107T PT946546E (pt) | 1996-11-21 | 1997-11-20 | Derivados da piridin-2-il-metilamina processo de preparacao e aplicacao daqueles como medicamentos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6020345A (pt) |
| EP (1) | EP0946546B1 (pt) |
| JP (1) | JP4248605B2 (pt) |
| CN (1) | CN1098263C (pt) |
| AT (1) | ATE243691T1 (pt) |
| AU (1) | AU732470B2 (pt) |
| BR (1) | BR9713126B1 (pt) |
| CA (1) | CA2272460C (pt) |
| DE (1) | DE69723104T2 (pt) |
| DK (1) | DK0946546T3 (pt) |
| ES (1) | ES2202647T3 (pt) |
| FR (1) | FR2755967B1 (pt) |
| PT (1) | PT946546E (pt) |
| WO (1) | WO1998022459A1 (pt) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329670B1 (en) | 1997-12-22 | 2008-02-12 | Bayer Pharmaceuticals Corporation | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| US7517880B2 (en) * | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| US20080300281A1 (en) * | 1997-12-22 | 2008-12-04 | Jacques Dumas | Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas |
| FR2784378B1 (fr) * | 1998-10-09 | 2000-12-29 | Pf Medicament | Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| US20080269265A1 (en) * | 1998-12-22 | 2008-10-30 | Scott Miller | Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| ES2377847T3 (es) * | 1999-01-13 | 2012-04-02 | Bayer Healthcare Llc | Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38 |
| EP1140840B1 (en) * | 1999-01-13 | 2006-03-22 | Bayer Pharmaceuticals Corp. | -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| ME00275B (me) * | 1999-01-13 | 2011-02-10 | Bayer Corp | ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE |
| US7928239B2 (en) | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| US7235576B1 (en) | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| FR2820743B1 (fr) * | 2001-02-09 | 2005-02-25 | Pf Medicament | Procede et intermediaires de synthese pour la preparation de derives de pyridin-2-yl-methylamine |
| US7371763B2 (en) * | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| US20060167074A1 (en) * | 2001-06-19 | 2006-07-27 | Norbert Muller | Methods and compositions for the treatment of psychiatric disorders |
| DE10129320A1 (de) * | 2001-06-19 | 2003-04-10 | Norbert Mueller | Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen |
| US8106074B2 (en) | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
| FR2827172B1 (fr) * | 2001-07-13 | 2004-07-02 | Pf Medicament | Derives de pyridin-2-yl-methylamine pour le traitement de la dependance aux opioides |
| PT2305255E (pt) * | 2001-12-03 | 2012-09-04 | Bayer Healthcare Llc | Compostos de arilureia em combinação com outros agentes citostáticos ou citotóxicos para tratamento de cancros humanos |
| US20080108672A1 (en) * | 2002-01-11 | 2008-05-08 | Bernd Riedl | Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors |
| EP1474393A1 (en) * | 2002-02-11 | 2004-11-10 | Bayer Pharmaceuticals Corporation | Aryl ureas as kinase inhibitors |
| US20040023961A1 (en) * | 2002-02-11 | 2004-02-05 | Bayer Corporation | Aryl ureas with raf kinase and angiogenisis inhibiting activity |
| SI1478358T1 (sl) * | 2002-02-11 | 2013-09-30 | Bayer Healthcare Llc | Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi |
| AU2003209119A1 (en) | 2002-02-11 | 2003-09-04 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
| KR100435105B1 (ko) * | 2002-04-17 | 2004-06-09 | 금호석유화학 주식회사 | 카르복시이미데이트 리간드에 기초한 원자이동 라디칼중합을 이용한 새로운 메틸메타아크릴레이트의 중합방법 |
| FR2840900B1 (fr) * | 2002-06-18 | 2005-02-25 | Pf Medicament | Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| US7557129B2 (en) * | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| FR2852244B1 (fr) * | 2003-03-13 | 2007-09-07 | Pf Medicament | Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene |
| DK1626714T3 (da) * | 2003-05-20 | 2007-10-15 | Bayer Pharmaceuticals Corp | Dirarylurinstoffer mod sygdomme medieret af PDGFR |
| RS52625B (en) * | 2003-07-23 | 2013-06-28 | Bayer Healthcare Llc | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES |
| FR2891274B1 (fr) * | 2005-09-27 | 2007-11-23 | Pierre Fabre Medicament Sa | Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires. |
| EP2058306A1 (en) * | 2007-11-08 | 2009-05-13 | Schwarz Pharma Ag | Heteroaryl-substituted 2-pyridinyl-methylamine derivatives |
| AU2012245344B2 (en) * | 2011-04-22 | 2017-11-09 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
| US10548885B2 (en) | 2014-07-09 | 2020-02-04 | Pierre Fabre Medicament | Method for treating movement disorders with befiradol |
| EP3260452A1 (en) * | 2016-06-24 | 2017-12-27 | Neurolixis | Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-ht1a receptors |
| US10626105B2 (en) * | 2016-09-22 | 2020-04-21 | Auspex Pharmaceuticals, Inc. | Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds |
| PL3664787T3 (pl) | 2017-07-20 | 2022-10-24 | Neurolixis | Zastosowanie selektywnych agonistów receptora serotoninowego 5-HT1A do leczenia skutków ubocznych inhibitorów VMAT |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| EP0661266A1 (en) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituted cyclic amine compounds as 5HT2 antagonists |
-
1996
- 1996-11-21 FR FR9614217A patent/FR2755967B1/fr not_active Expired - Lifetime
-
1997
- 1997-11-20 PT PT97947107T patent/PT946546E/pt unknown
- 1997-11-20 WO PCT/FR1997/002097 patent/WO1998022459A1/fr active IP Right Grant
- 1997-11-20 AU AU52276/98A patent/AU732470B2/en not_active Expired
- 1997-11-20 JP JP52329298A patent/JP4248605B2/ja not_active Expired - Lifetime
- 1997-11-20 US US09/308,613 patent/US6020345A/en not_active Expired - Lifetime
- 1997-11-20 AT AT97947107T patent/ATE243691T1/de active
- 1997-11-20 DK DK97947107T patent/DK0946546T3/da active
- 1997-11-20 ES ES97947107T patent/ES2202647T3/es not_active Expired - Lifetime
- 1997-11-20 BR BRPI9713126-1A patent/BR9713126B1/pt not_active IP Right Cessation
- 1997-11-20 CN CN97181172A patent/CN1098263C/zh not_active Expired - Lifetime
- 1997-11-20 CA CA002272460A patent/CA2272460C/fr not_active Expired - Lifetime
- 1997-11-20 EP EP97947107A patent/EP0946546B1/fr not_active Expired - Lifetime
- 1997-11-20 DE DE69723104T patent/DE69723104T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| BR9713126A (pt) | 2000-04-11 |
| FR2755967A1 (fr) | 1998-05-22 |
| JP2001504129A (ja) | 2001-03-27 |
| DE69723104D1 (de) | 2003-07-31 |
| ES2202647T3 (es) | 2004-04-01 |
| ATE243691T1 (de) | 2003-07-15 |
| US6020345A (en) | 2000-02-01 |
| BR9713126B1 (pt) | 2009-01-13 |
| AU732470B2 (en) | 2001-04-26 |
| DE69723104T2 (de) | 2004-04-29 |
| FR2755967B1 (fr) | 1999-01-29 |
| JP4248605B2 (ja) | 2009-04-02 |
| CN1242772A (zh) | 2000-01-26 |
| WO1998022459A1 (fr) | 1998-05-28 |
| CA2272460A1 (fr) | 1998-05-28 |
| CN1098263C (zh) | 2003-01-08 |
| EP0946546B1 (fr) | 2003-06-25 |
| AU5227698A (en) | 1998-06-10 |
| EP0946546A1 (fr) | 1999-10-06 |
| DK0946546T3 (da) | 2003-10-20 |
| CA2272460C (fr) | 2009-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT946546E (pt) | Derivados da piridin-2-il-metilamina processo de preparacao e aplicacao daqueles como medicamentos | |
| BG108091A (en) | Quinazolines and mmp-13 inhibitors | |
| NO20074657L (no) | Nitrogenholdige aromatiske ringforbindelser | |
| PT910333E (pt) | Composicao desinfectante oral compreendendo cloreto de cetilpiridinio e um tensioactivo anfotero | |
| BR0116452A (pt) | Composto, composição farmacêutica, uso de um composto | |
| ES2169811T3 (es) | Nuevos derivados del acido piridonacarboxilico o sus sales y agente antibacteriano que comprende el mismo como ingrediente activo. | |
| HUP0300263A2 (hu) | Antranil-amid-származékok, alkalmazásuk és a vegyületeket hatóanyagként tartalmazó artropodicid készítmények | |
| ATE269312T1 (de) | N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| MXPA03000450A (es) | Sulfonamidas de ciclilamina como agonistas del receptor adrenergico beta-3. | |
| ATE416157T1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| DOP2000000106A (es) | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-isobutiramida | |
| IT1264988B1 (it) | Composizioni cosmetiche e dermatologiche per la protezione da radiazioni uv contenenti derivati dallo stilbene | |
| HUP0101132A2 (hu) | Amidvegyületet tartalmazó, szinergetikus hatású fungicid hatóanyag keverék és alkalmazása | |
| AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
| ATE172454T1 (de) | Pyridazinon derivate mit pharmazeutischer wirkung | |
| DK0683777T3 (da) | Oxindol-1-N-(alkoxycarbonyl)carboxamider og -1-(N-carboxamido)carboxamider som antiinflammatoriske midler | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| YU82493A (sh) | Novi postupak za dobivanje sumpornih derivata imidazola i dobiveni intermedijeri | |
| NO20050764L (no) | Forbindelser | |
| TR200001122T2 (tr) | Farmasötikler olarak bifenil türevleri. | |
| PT100001A (pt) | Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos | |
| NO992870L (no) | Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem | |
| ATE250591T1 (de) | Sulfonyloxadiazolone | |
| HUP0002132A2 (hu) | Új arilpiperazinilalkil-3(2H)-piridazinon-vegyületek, eljárás előállításukra és hatóanyagként ilyen vegyületeket tartalmazó készítmények |